Comparison of point of care and laboratory HbA1c analysis: A MetroNet study

Journal of the American Board of Family Medicine

Volumn 22, Issue 4, 2009, Pages 461-463

  Schwartz, Kendra L ^a   Monsur, Joseph ^a   Hammad, Adnan ^b   Bartoces, Monina G ^a   Neale, Anne Victoria ^a,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b Arab Community Center for Economic and Social Services   (United States)

^c Department of Family Medicine and Public Health Sciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; LABORATORY TEST; MEDICAL PRACTICE; POINT OF CARE TESTING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIAGNOSTIC TESTS, ROUTINE; FAMILY PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MICHIGAN; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 67650866740     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2009.04.090057     Document Type: Article

References (10)

1. Khunti K, Stone MA, Burden AC, et al. Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus. Br J Gen Pract 2006;56:511-517 (Pubitemid 43984468)
2. Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999;22:1785-1789 (Pubitemid 29521862)
3. Kennedy L, Herman WH, for the GOAL A1c study team. Glycated hemoglobin assessment in clinical practice: Comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study). Diabetes Techno Ther 2005;7:907-912
4. Schwartz KL, Monsur JC, Bartoces MG, West PA, Neale AV. Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study. BMC Fam Pract 2005;6:28-34.
5. Sicard DA, Taylor JR. Comparison of point-of-care HbA1c test versus standardized laboratory testing. Ann Pharmacother 2005;39:1024-1028
6. St. John A, Davis TME, Goodall I, Townsend MA, Price CP. Nurse-based evaluation of point-of-care assays for glycated haemoglobin. Clin Chim Acta 2006;365:257-263 (Pubitemid 43196446)
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
8. American Diabetes Association. Standards of medical care in diabetes, 2007. Diabetes Care 2007;30(supplement):S4-S41.
9. Hickner J, Graham DG, Elder NC, et al. Testing process errors and their harms and consequences reported from family medicine practices: a study of the American Academy of Family Physicians National Research Network. Qual Saf Health Care 2008;17:194-200.
10. Wehmeier M, Arendt BT, Schumann G, Külpmann WR. Evaluation and quality assessment of glucose concentration measurement in blood by point-of-care testing devices. Clin Chem Lab Med 2006;44:888-893 (Pubitemid 43911566)